<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://www.neuroblastomafoundation.org/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Neuroblastoma Research</title><link>http://www.neuroblastomafoundation.org/blogs/research/default.aspx</link><description /><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP2 (Build: 40407.4157)</generator><item><title>Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/ceruloplasmin-deficiency-reduces-levels-of-iron-and-bdnf-in-the-cortex-and-striatum-of-young-mice-and-increases-their-vulnerability-to-stroke.aspx</link><pubDate>Sat, 04 Feb 2012 11:46:08 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23711</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23711</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/ceruloplasmin-deficiency-reduces-levels-of-iron-and-bdnf-in-the-cortex-and-striatum-of-young-mice-and-increases-their-vulnerability-to-stroke.aspx#comments</comments><description>Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke. PLoS One. 2011;6(9):e25077 Authors: Texel SJ, Zhang J, Camandola S, Unger EL, Taub DD, Koehler RC, Harris ZL...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/ceruloplasmin-deficiency-reduces-levels-of-iron-and-bdnf-in-the-cortex-and-striatum-of-young-mice-and-increases-their-vulnerability-to-stroke.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23711" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/PLoS+One/default.aspx">PLoS One</category></item><item><title>Acitretin, an Enhancer of Alpha-Secretase Expression, Crosses the Blood-Brain Barrier and Is Not Eliminated by P-Glycoprotein.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/acitretin-an-enhancer-of-alpha-secretase-expression-crosses-the-blood-brain-barrier-and-is-not-eliminated-by-p-glycoprotein.aspx</link><pubDate>Sat, 04 Feb 2012 11:46:08 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23710</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23710</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/acitretin-an-enhancer-of-alpha-secretase-expression-crosses-the-blood-brain-barrier-and-is-not-eliminated-by-p-glycoprotein.aspx#comments</comments><description>Acitretin, an Enhancer of Alpha-Secretase Expression, Crosses the Blood-Brain Barrier and Is Not Eliminated by P-Glycoprotein. Neurodegener Dis. 2012 Feb 1; Authors: Holthoewer D, Endres K, Schuck F, Hiemke C, Schmitt U, Fahrenholz F Abstract Background...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/acitretin-an-enhancer-of-alpha-secretase-expression-crosses-the-blood-brain-barrier-and-is-not-eliminated-by-p-glycoprotein.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23710" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Neurodegener+Dis/default.aspx">Neurodegener Dis</category></item><item><title>The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/the-dopamine-metabolite-aminochrome-inhibits-mitochondrial-complex-i-and-modifies-the-expression-of-iron-transporters-dmt1-and-fpn1.aspx</link><pubDate>Sat, 04 Feb 2012 11:46:07 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23709</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23709</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/the-dopamine-metabolite-aminochrome-inhibits-mitochondrial-complex-i-and-modifies-the-expression-of-iron-transporters-dmt1-and-fpn1.aspx#comments</comments><description>The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. Biometals. 2012 Feb 3; Authors: Aguirre P, Urrutia P, Tapia V, Villa M, Paris I, Segura-Aguilar J, Núñez MT Abstract Hallmarks...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/the-dopamine-metabolite-aminochrome-inhibits-mitochondrial-complex-i-and-modifies-the-expression-of-iron-transporters-dmt1-and-fpn1.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23709" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Biometals/default.aspx">Biometals</category></item><item><title>Novel GαS-Protein Signaling Associated with Membrane-Tethered Amyloid Precursor Protein Intracellular Domain.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/novel-g-s-protein-signaling-associated-with-membrane-tethered-amyloid-precursor-protein-intracellular-domain.aspx</link><pubDate>Sat, 04 Feb 2012 11:45:40 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23708</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23708</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/novel-g-s-protein-signaling-associated-with-membrane-tethered-amyloid-precursor-protein-intracellular-domain.aspx#comments</comments><description>Novel GαS-Protein Signaling Associated with Membrane-Tethered Amyloid Precursor Protein Intracellular Domain. J Neurosci. 2012 Feb 1;32(5):1714-29 Authors: Deyts C, Vetrivel KS, Das S, Shepherd YM, Dupré DJ, Thinakaran G, Parent AT Abstract Numerous physiological...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/04/novel-g-s-protein-signaling-associated-with-membrane-tethered-amyloid-precursor-protein-intracellular-domain.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23708" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/J+Neurosci/default.aspx">J Neurosci</category></item><item><title>An extension of the single threshold design for monitoring efficacy and safety in phase II clinical trials.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/an-extension-of-the-single-threshold-design-for-monitoring-efficacy-and-safety-in-phase-ii-clinical-trials.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:05 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23589</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23589</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/an-extension-of-the-single-threshold-design-for-monitoring-efficacy-and-safety-in-phase-ii-clinical-trials.aspx#comments</comments><description>An extension of the single threshold design for monitoring efficacy and safety in phase II clinical trials. Stat Med. 2011 Jun 30;30(14):1648-64 Authors: Brutti P, Gubbiotti S, Sambucini V Abstract Tan and Machin (biStat. Med. 2002; 21:1991-2012) introduce...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/an-extension-of-the-single-threshold-design-for-monitoring-efficacy-and-safety-in-phase-ii-clinical-trials.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23589" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Stat+Med/default.aspx">Stat Med</category></item><item><title>Childhood cancer incidence and survival 2003-2005, Thailand: study from the thai pediatric oncology group.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/childhood-cancer-incidence-and-survival-2003-2005-thailand-study-from-the-thai-pediatric-oncology-group.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:05 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23588</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23588</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/childhood-cancer-incidence-and-survival-2003-2005-thailand-study-from-the-thai-pediatric-oncology-group.aspx#comments</comments><description>Childhood cancer incidence and survival 2003-2005, Thailand: study from the thai pediatric oncology group. Asian Pac J Cancer Prev. 2011;12(9):2215-20 Authors: Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, Sripaiboonkij N Abstract...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/childhood-cancer-incidence-and-survival-2003-2005-thailand-study-from-the-thai-pediatric-oncology-group.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23588" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Asian+Pac+J+Cancer+Prev/default.aspx">Asian Pac J Cancer Prev</category></item><item><title>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/cellular-consequences-of-the-expression-of-alzheimer-s-disease-causing-presenilin-1-mutations-in-human-neuroblastoma-sh-sy5y-cells.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:05 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23587</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23587</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/cellular-consequences-of-the-expression-of-alzheimer-s-disease-causing-presenilin-1-mutations-in-human-neuroblastoma-sh-sy5y-cells.aspx#comments</comments><description>Cellular consequences of the expression of Alzheimer&amp;#39;s disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells. Brain Res. 2012 Jan 12; Authors: Boyle JP, Hettiarachchi NT, Wilkinson JA, Pearson HA, Scragg JL, Lendon C, Al-Owais...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/cellular-consequences-of-the-expression-of-alzheimer-s-disease-causing-presenilin-1-mutations-in-human-neuroblastoma-sh-sy5y-cells.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23587" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Brain+Res/default.aspx">Brain Res</category></item><item><title>Protection of prenylated flavonoids from mori cortex radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/protection-of-prenylated-flavonoids-from-mori-cortex-radicis-moraceae-against-nitric-oxide-induced-cell-death-in-neuroblastoma-sh-sy5y-cells.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:04 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23586</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23586</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/protection-of-prenylated-flavonoids-from-mori-cortex-radicis-moraceae-against-nitric-oxide-induced-cell-death-in-neuroblastoma-sh-sy5y-cells.aspx#comments</comments><description>Protection of prenylated flavonoids from mori cortex radicis (Moraceae) against nitric oxide-induced cell death in neuroblastoma SH-SY5Y cells. Arch Pharm Res. 2012 Jan;35(1):163-70 Authors: Lee HJ, Lyu da H, Koo U, Nam KW, Hong SS, Kim KO, Kim KH, Lee...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/protection-of-prenylated-flavonoids-from-mori-cortex-radicis-moraceae-against-nitric-oxide-induced-cell-death-in-neuroblastoma-sh-sy5y-cells.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23586" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Arch+Pharm+Res/default.aspx">Arch Pharm Res</category></item><item><title>Arylpiperazine Dopamineric Ligands Protect Neuroblastoma Cells from Nitric Oxide (NO)-Induced Mitochondrial Damage and Apoptosis.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/arylpiperazine-dopamineric-ligands-protect-neuroblastoma-cells-from-nitric-oxide-no-induced-mitochondrial-damage-and-apoptosis.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:04 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23585</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23585</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/arylpiperazine-dopamineric-ligands-protect-neuroblastoma-cells-from-nitric-oxide-no-induced-mitochondrial-damage-and-apoptosis.aspx#comments</comments><description>Arylpiperazine Dopamineric Ligands Protect Neuroblastoma Cells from Nitric Oxide (NO)-Induced Mitochondrial Damage and Apoptosis. ChemMedChem. 2012 Feb 1; Authors: Tovilovic G, Zogovic N, Harhaji-Trajkovic L, Misirkic-Marjanovic M, Janjetovic K, Vucicevic...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/arylpiperazine-dopamineric-ligands-protect-neuroblastoma-cells-from-nitric-oxide-no-induced-mitochondrial-damage-and-apoptosis.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23585" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/ChemMedChem/default.aspx">ChemMedChem</category></item><item><title>Tumor-initiating cells in childhood neuroblastoma--letter.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-letter.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:04 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23584</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23584</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-letter.aspx#comments</comments><description>Tumor-initiating cells in childhood neuroblastoma--letter. Cancer Res. 2012 Feb 1;72(3):821-2 Authors: Mohlin S, Pietras A, Wigerup C, Ora I, Andäng M, Nilsson K, Olofsson T, Gisselsson D, Påhlman S PMID: 22298597 [PubMed - in process]...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-letter.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23584" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Cancer+Res/default.aspx">Cancer Res</category></item><item><title>Tumor-initiating cells in childhood neuroblastoma--response.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-response.aspx</link><pubDate>Fri, 03 Feb 2012 11:06:04 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23583</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23583</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-response.aspx#comments</comments><description>Tumor-initiating cells in childhood neuroblastoma--response. Cancer Res. 2012 Feb 1;72(3):823-4 Authors: Hansford LM, Kaplan DR PMID: 22298598 [PubMed - in process]...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/tumor-initiating-cells-in-childhood-neuroblastoma-response.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23583" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Cancer+Res/default.aspx">Cancer Res</category></item><item><title>Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/activated-catenin-forces-n2a-cell-derived-neurons-back-to-tumor-like-neuroblasts-and-positively-correlates-with-a-risk-for-human-neuroblastoma.aspx</link><pubDate>Fri, 03 Feb 2012 11:05:52 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23582</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23582</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/activated-catenin-forces-n2a-cell-derived-neurons-back-to-tumor-like-neuroblasts-and-positively-correlates-with-a-risk-for-human-neuroblastoma.aspx#comments</comments><description>Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma. Int J Biol Sci. 2012;8(2):289-97 Authors: Zhi F, Gong G, Xu Y, Zhu Y, Hu D, Yang Y, Hu Y Abstract Neuroblastoma...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/03/activated-catenin-forces-n2a-cell-derived-neurons-back-to-tumor-like-neuroblasts-and-positively-correlates-with-a-risk-for-human-neuroblastoma.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23582" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Int+J+Biol+Sci/default.aspx">Int J Biol Sci</category></item><item><title>Influence of a 50 Hz magnetic field and of all-trans‑retinol on the             proliferation of human cancer cell lines.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/influence-of-a-50-hz-magnetic-field-and-of-all-trans-retinol-on-the-proliferation-of-human-cancer-cell-lines.aspx</link><pubDate>Thu, 02 Feb 2012 12:01:00 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23416</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23416</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/influence-of-a-50-hz-magnetic-field-and-of-all-trans-retinol-on-the-proliferation-of-human-cancer-cell-lines.aspx#comments</comments><description>Influence of a 50 Hz magnetic field and of all-trans‑retinol on the proliferation of human cancer cell lines. Int J Oncol. 2012 Jan 27; Authors: Trillo MA, Martínez MA, Cid MA, Leal J, Ubeda A Abstract In vitro exposure to power frequency magnetic fields...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/influence-of-a-50-hz-magnetic-field-and-of-all-trans-retinol-on-the-proliferation-of-human-cancer-cell-lines.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23416" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Int+J+Oncol/default.aspx">Int J Oncol</category></item><item><title>Shifting from Population-wide to Personalized Cancer Prognosis with Microarrays.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/shifting-from-population-wide-to-personalized-cancer-prognosis-with-microarrays.aspx</link><pubDate>Thu, 02 Feb 2012 12:00:59 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23415</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23415</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/shifting-from-population-wide-to-personalized-cancer-prognosis-with-microarrays.aspx#comments</comments><description>Shifting from Population-wide to Personalized Cancer Prognosis with Microarrays. PLoS One. 2012;7(1):e29534 Authors: Shao L, Fan X, Cheng N, Wu L, Xiong H, Fang H, Ding D, Shi L, Cheng Y, Tong W Abstract The era of personalized medicine for cancer therapeutics...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/02/shifting-from-population-wide-to-personalized-cancer-prognosis-with-microarrays.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23415" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/PLoS+One/default.aspx">PLoS One</category></item><item><title>Calpastatin upregulation in Mycoplasma hyorhinis-infected cells is promoted by the mycoplasma lipoproteins via the NF-κB pathway.</title><link>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/01/calpastatin-upregulation-in-mycoplasma-hyorhinis-infected-cells-is-promoted-by-the-mycoplasma-lipoproteins-via-the-nf-b-pathway.aspx</link><pubDate>Wed, 01 Feb 2012 11:41:59 GMT</pubDate><guid isPermaLink="false">9a7c9348-2ef3-4ddc-9fa4-361883222a9c:23285</guid><dc:creator>pubmed: neuroblastoma</dc:creator><slash:comments>0</slash:comments><wfw:commentRss xmlns:wfw="http://wellformedweb.org/CommentAPI/">http://www.neuroblastomafoundation.org/blogs/research/rsscomments.aspx?PostID=23285</wfw:commentRss><comments>http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/01/calpastatin-upregulation-in-mycoplasma-hyorhinis-infected-cells-is-promoted-by-the-mycoplasma-lipoproteins-via-the-nf-b-pathway.aspx#comments</comments><description>Calpastatin upregulation in Mycoplasma hyorhinis-infected cells is promoted by the mycoplasma lipoproteins via the NF-κB pathway. Cell Microbiol. 2012 Jan 31; Authors: Elkind E, Vaisid T, Kornspan JD, Barnoy S, Rottem S, Kosower NS Abstract Mycoplasma...(&lt;a href="http://www.neuroblastomafoundation.org/blogs/research/archive/2012/02/01/calpastatin-upregulation-in-mycoplasma-hyorhinis-infected-cells-is-promoted-by-the-mycoplasma-lipoproteins-via-the-nf-b-pathway.aspx"&gt;read more&lt;/a&gt;)&lt;img src="http://www.neuroblastomafoundation.org/aggbug.aspx?PostID=23285" width="1" height="1"&gt;</description><category domain="http://www.neuroblastomafoundation.org/blogs/research/archive/tags/Cell+Microbiol/default.aspx">Cell Microbiol</category></item></channel></rss>
